Immunogenic compositions of
View Patent ↗The present invention relates to immunogenic compositions, comprising polypeptides isolated from Staphylococcus epidermidis . The invention also relates to polynucleotides encoding Staphylococcus epidermidis polypeptides and their use in immunogenic compostions. In addition, the invention relates to methods of inducing an immune response in mammals against Staphylococcus epidermidis and Staphylococcus aureus using immunogenic compostions of the Staphylococcus epidermidis polypeptides and polynucleotides. The invention also relates to methods for detecting Staphylococcus epidermidis in a biological sample.
1. An immunogenic composition comprising one or more isolated polypeptides consisting of the amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 13, and SEQ ID NO: 17, wherein the at least one of the one or more isolated polypeptides is a lipoprotein, and at least one of the one or more isolated polypeptides is derived from Staphylococcus epidermidis.
2. The immunogenic composition of claim 1 , wherein the one or more isolated polypeptides are immunoreactive with antibodies in the serum of rabbits infected with Staphylococcus epidermidis.
3. The immunogenic composition of claim 2 , wherein the one or more isolated polypeptides bind to one or more rabbit serum proteins.
4. The immunogenic composition according to claim 1 , further comprising a pharmaceutically acceptable carrier.
5. The immunogenic composition according to claim 4 , further comprising one or more adjuvants.
6. An immunogenic composition comprising one or more isolated polypeptides consisting of an heterologous amino acid sequence and an amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 13, and SEQ ID NO: 17.
7. The immunogenic composition according to claim 6 , wherein the at least one of the one or more isolated polypeptides is a fusion polypeptide.
8. The immunogenic composition according to claim 7 , wherein the at least one of the one or more isolated polypeptides is a recombinant polypeptide.
9. The immunogenic composition according to claim 1 , said composition further comprising a Staphylococcus epidermidis polysaccharide antigen.
10. The immunogenic composition according to claim 1 , said composition further comprising a Staphylococcus aureus polysaccharide or polypeptide antigen.
11. An immunogenic composition comprising one or more isolated polypeptides consisting of the amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 13, SEQ ID NO: 17 and SEQ ID NO: 22 and further comprising an isolated Staphylococcus epidermidis polypeptide consisting of SEQ ID NO: 14.
12. A method of inducing an immune response against Staphylococcus epidermidis comprising administering to a mammal an immunogenic amount of an immunogenic composition according to claim 1 .
13. The method of claim 12 , wherein the immunogenic composition further comprises an adjuvant.
14. The method of claim 12 , wherein at least one of the one or more isolated polypeptides is a recombinant polypeptide.
15. The immunogenic composition according to claim 1 , wherein one of the one or more isolated polypeptides consists of the amino acid sequence of SEQ ID NO: 2.
16. The immunogenic composition according to claim 1 , wherein one of the one or more isolated polypeptides consists of the amino acid sequence of SEQ ID NO: 13.
17. The immunogenic composition according to claim 1 , wherein one of the one or more isolated polypeptides consists of the amino acid sequence of SEQ ID NO: 17.
18. An immunogenic composition comprising one or more isolated polypeptides consisting of the amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 13, and SEQ ID NO: 17 and further comprising an isolated Staphylococcus epidermidis polypeptide consisting of SEQ ID NO: 22.
19. A method of inducing an immune response against Staphylococcus epidermidis comprising administering to a mammal an immunogenic amount of an immunogenic composition according to claim 6 .
20. The method of claim 19 , wherein at least one of the one or more isolated polypeptides is a fusion polypeptide.
21. The method of claim 19 , wherein the immunogenic composition further comprises an adjuvant.